Gennex Laboratories Board of Directors
Get the latest insights into the leadership at Gennex Laboratories. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Arihant Baid | Managing Director |
| Dr. A R R Pantulu | Non Executive Director |
| Mr. Sandeep Kumar Daga | Non Executive Director |
| Mr. A S Nageswar Rao | Independent Director |
| Mr. Dilip Raj Singhvi | Independent Director |
| Ms. Shilpa Bung | Independent Woman Director |
Gennex Laboratories Share price
GENNEX
12.89
0.05 (-0.39%)Last updated on 16 Dec, 2025 | 10:19 IST
BUYSELL
Today's High
13.04
Today's Low
12.75
52 Week Low
10.84
52 Week High
19.00
The current prices are delayed, login to your account for live prices
Login Gennex Laboratories FAQs
The board at Gennex Laboratories consists of experienced professionals, including Mr. Arihant Baid , Dr. A R R Pantulu , and others, overseeing the company’s strategic and corporate governance.
Directors at Gennex Laboratories are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Arihant Baid is the current chairman at Gennex Laboratories.
Executive directors at Gennex Laboratories are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Gennex Laboratories adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Gennex Laboratories, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
